SEC Form D filing

SelSym Biotech, Inc., 2026-07-15

An SEC Form D private-offering notice from Durham, NC, a $1,500,000 filer-stated offering target in Biotech. Filed 2026-07-15. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

SelSym Biotech, Inc. site↗ Verified via SEC Form D

SelSym Biotech develops platelet mimetic hemostatic therapeutics for hemorrhage control and wound healing, based in Durham, North Carolina.

Filed 2026-07-15Filed to raise $1,500,000First money in 2026-07-02Raised so far $500,000HQ (as filed) Durham, NCSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified selsymbio.com↗Named in the filing 3 executives & directors
Open this row on the live feed →More new filings in North Carolina →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source